Reneo Pharmaceuticals Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Reneo Pharmaceuticals Inc
Access all reports
Reneo Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on developing therapies for patients with rare genetic mitochondrial diseases. These diseases often involve the mitochondria's inability to efficiently produce energy for cells, impacting various bodily functions. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Latest articles
Robinhood: Revolutionizing Retail Investing
Since launching in 2015, Robinhood has transformed retail investing in the U.S., consistently broadening its offering to meet customer needs.
7 Nov 2024
Doug McMillon: Walmart's CEO, Decades in the Making
Doug McMillon has spent over four decades at Walmart, starting as a summer associate and rising to become the CEO of the global retail giant.
6 Nov 2024
Unleash the Beast: The Juicy Origins of Monster Beverage
Starting as a family-run juice business in the 1930s, Monster has transformed through bold, innovative branding and marketing into a global energy drink leader.
31 Oct 2024
Ticker symbol
RPHM
Country
🇺🇸 United States